Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma

Am J Hematol. 2023 Mar;98(3):E61-E64. doi: 10.1002/ajh.26810. Epub 2022 Dec 21.

Authors

Peiyu Yang^{1

2}, Weiling Xu³, Xinyue Liang¹, Shanshan Yu¹, Xingcheng Yi², Mengmeng Liu¹, Mengru Tian^{1

2}, Tingting Yue^{1

2}, Yingjie Zhang^{1

2}, Yurong Yan¹, Zhongli Hu¹, Qiang Guo¹, Nan Zhang¹, Jingxuan Wang¹, Xiaoxiao Sun¹, Rui Hu¹, Shaji K Kumar⁴, Yun Dai², Fengyan Jin¹

Affiliations

¹ Hematology Department, First Hospital of Jilin University, Changchun, Jilin, China.
² Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
³ Radiology Department, First Hospital of Jilin University, Changchun, Jilin, China.
⁴ Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

PMID: 36540935
DOI: 10.1002/ajh.26810

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Multiple Myeloma* / diagnosis
Multiple Myeloma* / therapy
Neoplasm, Residual / diagnosis